OCRELIZUMAB
ocrelizumab 920 mg/23 mL injection, 23 mL vial
OCRELIZUMAB (15113K)
15113K
Manner of administration:Injection
Restriction (Streamlined authority code: 9523)
Indication: Multiple sclerosis
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 9635)
Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $16,705.24 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ocrevus SC | |||||